Cite
MLA Citation
A. Johne et al.. “369 Open-label, single center, phase I trial to investigate the mass balance and absolute bioavailability of the oral c-Met inhibitor tepotinib.” European journal of cancer, vol. 51, n.d., pp. S77–. http://access.bl.uk/ark:/81055/vdc_100030628020.0x00004e